Galapagos NV: business update: http://t.co/6w1jppWE
posted 4 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
De ‘Willen Winnen Award’ is een prijs die uitgereikt wordt door Voka – Kamer van Koophandel Kempen - aan een verdienstelijk bedrijf uit de regio. De prijs gaat naar een jonge, ambitieuze onderneming die durf en wendbaarheid aan de dag legt. Een onderneming die gelooft in de toekomst en timmert aan de weg. Misschien nog net iets te jong om qua resultaten al in de lijn te liggen van het rijtje indrukwekkende winnaars van de Prijs Ondernemen. Maar de nadruk ligt op ‘nog niet’, want de bedrijven die de ‘Willen Winnen Award’ krijgen zijn absoluut kandidaten om de Prijs Ondernemen in de toekomst in de wacht te slepen. Want willen winnen is wat deze bedrijven kenmerkt. read more
Research Institute for Chromatography (R.I.C.) announces that it and its consortium partners have been awarded a grant within Eureka’s Eurostars™ program with a total budget of €1.7 million for the development of a biosimilar monoclonal antibody in a Quality by Design approach. R.I.C. will apply its chromatographic and mass spectrometric expertise throughout the project. One of the co-applicants is Bioceros BV (Utrecht, The Netherlands) that will be responsible for the monoclonal antibody generation using its proprietary CHOBC® production platform. read more
Kevin Verstrepen of VIB-K.U.Leuven has been selected by the European Molecular Biology Organization (EMBO) to receive support from the Young Investigator Programme. The prize is in recognition for his pioneering research in the development and biology of yeast. read more
Galapagos NV (Euronext: GLPG) announced that it won the European Biotechnica Award at last night’s ceremony in Hannover. Presented each year by the Deutsche Messe, the Biotechnica award recognizes European-based biotechnology companies that have developed particularly innovative products, services and business ideas. read more
Movetis NV (MOVE), the European gastrointestinal (GI) speciality pharmaceutical company, announces today that it has won the European Financing Deal of the Year and the European M&A Deal of the Year at the PharmaVentures European Deals 2010 Awards. The awards recognise Movetis’ successful IPO on Euronext Brussels in December 2009, as well as the recent public tender offer by Shire on all outstanding shares and warrants of Movetis. These prestigious awards were presented yesterday night at the Sachs Associates 10th Annual Biotech in Europe Investor Forum in Zurich. read more
